In its nanotech action plan 2005-2009 (released last June) the European Commission said it would ask experts to carry out an ethical analysis of nanomedicine. Last month, President of the European Commission José Manuel Barroso appointed the 15 members of the European Group on Ethics in Science and New Technologies (EGE, 2005-2009 mandate), a multidisciplinary body providing advice to the European Commission in connection with the preparation and implementation of Community legislation or policies. This will be the mission of the EGE to examine ethical aspects of nanomedicine: during a meeting held in Brussels on 25 October, the Group officially included nanomedicine subject in its early work programme (second topic is stem cell). The next EGE meeting is scheduled for 15 and 16 November in London, under the UK Presidency. EGE also plans to organise in January 2006 in Brussels, a round-table debate on the ethical aspects of Nanomedicine, in order to discuss the topic with scientific experts, lawyers, philosophers, as well as representatives from the European Parliament, international organisations, representatives of patients, industry, religions, and other interested parties.